allergic reactions to glp 1 Understanding the Side Effects of GLP-1 Medications Redness After GLP-1 Pen Injection:

Semaglutide was approved in 2022 for use alongside lifestyle changes in pediatric patients aged 12 or older with an initial BMI equal to or greater than the 95th percentile for their age and sex

The future of tirzepatide alternatives The pipeline of weight management medications has never been fuller

It runs for 80 weeks (the longest in the program), enrolls a general obesity population without type 2 diabetes, and is designed to be the direct apples-to-apples analogue of SURMOUNT-1 (tirzepatide) and STEP-1 (semaglutide)

Cruzado JM, Rico J, Grinyo JM

These systems illustrate how biologically validated peptides can be reassessed using modern pharmacologic principles to uncover therapeutic opportunities previously obscured

doi: 10.1016/j.jada.2008.12.019